Skip to main content
. 2024 Mar 1;38:100838. doi: 10.1016/j.lanepe.2024.100838

Table 6.

Available biomarker test types for patients with metastatic NSCLC in participating centers (of clinical scientist in molecular pathology/(molecular) pathologist).

graphic file with name fx5.gif